HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yim Man Selected Research

omipalisib

1/2019A randomised, placebo-controlled study of omipalisib (PI3K/mTOR) in idiopathic pulmonary fibrosis.
1/2016Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yim Man Research Topics

Disease

3Idiopathic Pulmonary Fibrosis
01/2020 - 01/2016
2Fibrosis (Cirrhosis)
12/2021 - 01/2020
1Disease Progression
01/2020
1Neoplasms (Cancer)
01/2016

Drug/Important Bio-Agent (IBA)

2Bleomycin (Blenoxane)FDA LinkGeneric
12/2021 - 01/2020
2Transforming Growth Factors (Transforming Growth Factor)IBA
12/2021 - 01/2020
2IntegrinsIBA
12/2021 - 01/2020
2CollagenIBA
12/2021 - 01/2020
2omipalisibIBA
01/2019 - 01/2016
1CytokinesIBA
12/2021
1GSK3008348IBA
01/2020
1TOR Serine-Threonine KinasesIBA
01/2019
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
01/2019
1Phosphotransferases (Kinase)IBA
01/2016

Therapy/Procedure

1Therapeutics
01/2016